Contrast Medium Induced Nephropathy after Endovascular Stent Graft Placement: An Examination of Its Prevalence and Risk Factors
Table 2
Clinical parameters and outcomes.
Parameter
CIN
Non-CIN
Total
value
Preoperative creatinine (mg/dL)
1.06 ± 0.364
0.91 ± 0.317
0.931 ± 0.332
0.191
Postoperative creatinine (mg/dL)
1.55 ± 0.600
0.883 ± 0.281
0.935 ± 0.362
<0.001
Changes in creatinine level (mg/dL)
0.490 ± 0.303
−0.036 ± 157
0.00451 ± 0.222
<0.001
Preoperative eGFR (mL/min/1.73 m2)
57.5 ± 19.9
65.1 ± 19.9
64.5 ± 19.4
0.211
Postoperative eGFR (mL/min/1.73 m2)
38.9 ± 14.4
67.5 ± 20.0
65.3 ± 21.0
<0.001
Changes in eGFR (mL/min/1.73 m2)
−18.7 ± 8.66
2.44 ± 9.43
0.797 ± 10.9
<0.001
Operative procedure (TEVAR)
7 [53.8%]
68 [44.2%]
75 [44.9%]
0.569
Intraoperative red blood cell transfusion
3 [23.1%]
7 [45.5%]
10 [59.9%]
0.032
Operative time (min)
125 ± 59.9
115 ± 60.0
118 ± 57.8
0.567
Successful endovascular treatment
13 [100%]
154 [100%]
167 [100%]
NS
CV/eGFR
2.23 ± 1.42
1.53 ± 0.777
1.589 ± 0.859
0.005
CV age
8560 ± 5129
6534 ± 3048
6691 ± 3280
0.032
Data are presented as the mean ± standard deviation or [%]. CIN: contrast-induced nephropathy; eGFR: estimated glomerular filtration rate; TEVAR: thoracic endovascular aortic/aneurysm repair; NS: not significant; CV: contrast volume.
